Template:Paraneoplastic syndrome: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''P...") |
No edit summary |
||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome (patient information)|Patient | [[Paraneoplastic syndrome (patient information)|Patient Information]] | ||
|- | |- | ||
|- | |- | ||
| Line 35: | Line 35: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome classification|Classification]] | ||
|- | |- | ||
! | ! | ||
| Line 41: | Line 41: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
| Line 47: | Line 47: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome causes|Causes]] | ||
|- | |- | ||
! | ! | ||
| Line 53: | Line 53: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome differential diagnosis|Differentiating Paraneoplastic syndrome from other Diseases]] | ||
|- | |- | ||
! | ! | ||
| Line 59: | Line 59: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
| Line 65: | Line 65: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
| Line 71: | Line 71: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome natural history, complications, and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
| Line 89: | Line 83: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Paraneoplastic syndrome history and symptoms|History | [[Paraneoplastic syndrome history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
| Line 101: | Line 95: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Paraneoplastic syndrome laboratory tests| | [[Paraneoplastic syndrome laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 119: | Line 113: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome CT|CT]] | ||
|- | |- | ||
! | ! | ||
| Line 125: | Line 119: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Paraneoplastic syndrome | [[Paraneoplastic syndrome MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
| Line 193: | Line 187: | ||
[[Paraneoplastic syndrome future or investigational therapies|Future or Investigational Therapies]] | [[Paraneoplastic syndrome future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Paraneoplastic syndrome case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " | ||
Revision as of 13:16, 12 September 2012
|
Paraneoplastic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Paraneoplastic syndrome On the Web |
|
American Roentgen Ray Society Images of Paraneoplastic syndrome |
|
Risk calculators and risk factors for Paraneoplastic syndrome |